UBS Group’s BioAmber Inc. BIOA.WS Stock Holding History

UBS Group’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,350	Closed	–	–	8468
2017 Q1	$0	Sell	1,350 -1,200	-47%	-$349	﹤0.01%	8479
2016 Q4	$2K	Buy	+2,550	New	+$1.18K	﹤0.01%	7585
2016 Q3	–	Sell	-400	Closed	–	–	8404
2016 Q2	$0	Hold	400	–	–	﹤0.01%	8426
2016 Q1	$1K	Buy	+400	New	+$597	﹤0.01%	7553
2015 Q4	–	Sell	-1,000	Closed	-$2K	–	8999
2015 Q3	$2K	Buy	+1,000	New	+$1.88K	﹤0.01%	8175

UBS Group's BIOA.WS Position: Q2 2017 in Review

UBS Group sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 1,350 shares.

UBS Group first reported a position in BIOA.WS in Q3 2015 and held it in 5 quarters. The position peaked at $2K in Q4 2016. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.

UBS Group reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
UBS Group sold 1,350 BioAmber Inc. shares in Q2 2017.
UBS Group first reported a position in BioAmber Inc. in Q3 2015 and held it in 5 quarters.
UBS Group's BioAmber Inc. position peaked at $2K in Q4 2016.
0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.